Recent announcements by PAA on MND clinical trials have been within the ASX and TGA guidelines for announcements..
guidance-for-asx-announcements(4).pdf
Shareholders should take a quick look and familiarise themselves with this easy to understand Guidance Report.
Ann: Additional Phase 1 data suggest MPL may inhibit MND, page-193
-
- There are more pages in this discussion • 188 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NUZ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
0.015(8.11%) |
Mkt cap ! $98.34M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 20.0¢ | 19.0¢ | $66.44K | 346.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 86359 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 107894 | 5 |
View Market Depth
| Last trade - 15.42pm 13/11/2024 (20 minute delay) ? |
| NUZ (ASX) Chart |